PCN70 Cost Effectiveness Analysis Based on Progression Free...

PCN70 Cost Effectiveness Analysis Based on Progression Free Survival (PFS) of Pazopanib Versus Sunitinib for the Treatment of Advanced Renal Cell Carcinoma (ARCC) in the Mexican Context

Anaya, P., Delea, T.E., Pichardo, P., Diaz, J.R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
15
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2012.03.1187
Date:
June, 2012
File:
PDF, 61 KB
english, 2012
Conversion to is in progress
Conversion to is failed